Dr. Christopher John Busken, MD

Dr. Busken practices at Methodist Hospital Texsan in San Antonio, Texas.

Dr. Busken's NPI, 1548313455, was assigned on January 22, 2007. Dr. Busken graduated from University of Missouri School of Medicine in 2006. Dr. Busken holds Texas license P5160.

Dr. Busken's primary practice is Methodist Hospital Texsan, at 6700 I-10 W, San Antonio, TX 78201 in Bexar County. The practice phone is (210) 575-4000.

Dr. Busken's primary practice is Methodist Hospital Texsan in San Antonio, Texas. Dr. Busken is also affiliated with Baptist Medical Center. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Dr. Busken to 3 more hospitals, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Busken practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Busken's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Busken is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Busken's licenses on file in 3 states: Texas, Georgia and South Carolina.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization, lymphedema and peripheral vascular disease among the conditions Dr. Busken treats.

CMS data shows 1,700 Medicare services from Dr. Busken across 26 procedure codes in 2024, for 342 Medicare patients. Medicare paid $155,274 for them.

CMS counts 342 Medicare patients who saw Dr. Busken in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Busken's median patient age at 73, with 49% women.

In 2024, Dr. Busken wrote 289 Medicare Part D claims for 90 patients. 83% of them were for generic drugs. CMS names the drug for 250 of them, across 5 drugs with 11 or more claims each, at $29,428 in total drug cost. In 2023, CMS named 281 claims across 7 drugs.

Dr. Busken accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of leg revascularization (restoring blood flow) by Dr. Busken, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Busken in 2015. The most frequent topics are Stents. Dr. Busken's most frequent co-authors are Bradley R. Grimsley, MD and William P. Shutze, MD.

CMS Open Payments shows 568 general payments to Dr. Busken from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Endologix, Inc. paid the most, $32,395.

Dr. Busken graduated from University of Missouri School of Medicine in 2006.

Dr. Busken is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.